Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer	Prostate Cancer Recurrent	Active, not recruiting	Phase 2	2021-09-28		NCT04114825

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
RhoVac APS	1

36 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aalborg University, Departmen of Urology	Aalborg	Denmark	1
Aarhus University Hospital, Department of Urology	Aarhus	Denmark	1
Carolina Urologic Research Center	Myrtle Beach	United States	55
Chesapeake Urology Research Associates	Towson	United States	11
CHU de Liège	Liège	Belgium	9
Clatterbridge Centre for Oncology	Liverpool	United Kingdom	1
Comprehensive Cancer Centers of Nevada	Las Vegas	United States	34
Gent University Hospital	Ghent	Belgium	2
GU Research Network/Urology Cancer Center	Omaha	United States	2
Herlev & Gentofte Hospital, Department of Urology	Herlev	Denmark	1
Hôpital Erasme	Liège	Belgium	1
Icahn School of Medicine at Mount Sinai Hospitals	New York	United States	1
Karolinska University Hospital	Stockholm	Sweden	87
Meilahti Tower Hospital	Helsinki	Finland	2
Nottingham University Hospital	Nottingham	United Kingdom	7
Odense University Hospital, Deparment of Urology	Odense	Denmark	1
Oulu University Hospital	Oulu	Finland	44
Rigshospitalet, Copenhagen Prostate Cancer Center	Copenhagen	Denmark	1
Royal Free London NHS Foundation Trust Royal Free Hospital	London	United Kingdom	1
Sahlgrenska University Hospital	Gothenburg	Sweden	96
Seinajoki Central Hospital	Seinäjoki	Finland	3
Skåne University Hospital	Malmö	Sweden	19
Studienpraxis Urologie	Nürtingen	Germany	1
Tampa Bay Medical Research	Clearwater	United States	8
Tampere University Hospital	Tampere	Finland	61

Clinical trials